These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4454686)

  • 1. ["CO-diffusion capacity" and blood gases in obstructive airway diseases and their behavior under bronchodilator therapy].
    Siemon G; Thoma R; Keller R
    Verh Dtsch Ges Inn Med; 1974; 80():906-8. PubMed ID: 4454686
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of salbutamol on the measurement of single-breath diffusing capacity.
    Yang J; Stanton J; Wang L; Beckert L; Frampton C; Burton D; Swanney MP
    Respirology; 2013 Nov; 18(8):1223-9. PubMed ID: 23701193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of bronchodilation on alveolar gas and lung mechanics.
    Quanjer PH; Tammeling GJ
    Bull Physiopathol Respir (Nancy); 1972; 8(1):175-7. PubMed ID: 5052519
    [No Abstract]   [Full Text] [Related]  

  • 4. The discriminatory value of single breath carbon monoxide diffusion coefficient (kCO) in chronic airways obstruction.
    Harris L
    Bull Physiopathol Respir (Nancy); 1973; 9(2):473-80. PubMed ID: 4778962
    [No Abstract]   [Full Text] [Related]  

  • 5. [Possibilities and limits of current lung function tests using routine methods].
    Keller R; Mahlich J
    Bull Schweiz Akad Med Wiss; 1971; 27(5):421-34. PubMed ID: 5142302
    [No Abstract]   [Full Text] [Related]  

  • 6. [Quality control and other important issues in the measurement of pulmonary diffusing capacity by the one-breath method].
    Zheng JP
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):723-5. PubMed ID: 18218197
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of ventilation changes in patients with obstructive bronchopneumopathy induced by bronchodilator drugs].
    De Benedetto F; Cervone M; De Blasio E; D'Ilario F; Fuciarelli R; Luciano A; Sborgia M
    Clin Ter; 1984 Jun; 109(6):509-17. PubMed ID: 6236941
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic effect of fominoben in obstructive respiratory disorders and respiratory insufficiency].
    Uhl O
    Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:338-4. PubMed ID: 4575175
    [No Abstract]   [Full Text] [Related]  

  • 9. [Correlation between pulmonary diffusing capacity (D CO) and blood gases during rest and exercise].
    Patsch J
    Wien Med Wochenschr; 1976 Jun; 126(25-27):402-4. PubMed ID: 983100
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavior of diffusion capacity for carbon monoxide in 2 groups of subjects with pulmonary tuberculosis and chronic obstructive bronchopathy].
    Lo Coco A
    G Ital Mal Torace; 1970; 24(1):27-30. PubMed ID: 5514979
    [No Abstract]   [Full Text] [Related]  

  • 11. [Testing of Eprazinone, a new drug with antiobstructive effect on the respiratory tract].
    Matthys H
    Med Welt; 1975 Mar; 26(11):520-1. PubMed ID: 1091804
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pulmonary function tests. Place of carbon monoxide transfer measurement].
    Darcet P; Blanchet F; Menier R; Rigaud M; Florentin E
    Nouv Presse Med; 1973 Dec; 2(43):2885-7. PubMed ID: 4773667
    [No Abstract]   [Full Text] [Related]  

  • 13. Pulmonary-function testing in the evaluation of bronchodilator agents.
    Menendez R; Kelly HW
    Clin Pharm; 1983; 2(2):120-8. PubMed ID: 6349904
    [No Abstract]   [Full Text] [Related]  

  • 14. Preserved diffusion capacity in children with cystic fibrosis.
    Merkus PJ; Govaere ES; Hop WH; Stam H; Tiddens HA; de Jongste JC
    Pediatr Pulmonol; 2004 Jan; 37(1):56-60. PubMed ID: 14679490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differentiated characterization of pulmonary diffusion].
    Dörp E; Hortian B
    Pneumologie; 1997 Apr; 51 Suppl 2():460-2. PubMed ID: 9244896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What is assured in the treatment of obstructive airway diseases?].
    Ulmer WT
    Internist (Berl); 1972 Dec; 13(12):507-13. PubMed ID: 4631608
    [No Abstract]   [Full Text] [Related]  

  • 17. [Spirographic evaluation of obstructive ventilation disorders].
    Schindl R; Mayer K; Aigner K
    Wien Med Wochenschr; 1975 Jul; 125(28-31):449-52. PubMed ID: 1220301
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of carbon monoxide (CO) single breath pulmonary diffusing capacity with non-rebreathing, open-circuit CO pulmonary diffusing capacity in healthy children.
    Suman OE; Thomas S; Beck KC; Mlcak RP; Herndon DN
    Pediatr Pulmonol; 2006 Nov; 41(11):1095-102. PubMed ID: 16986167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusing capacity of the lung for carbon monoxide.
    MacIntyre NR
    Respir Care Clin N Am; 1997 Jun; 3(2):221-33. PubMed ID: 9390909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Broncholytic inhalation therapy. Double-blind study hexoprenaline orziprenaline in chronic obstructive respiratory tract diseases].
    Debelić M
    Schweiz Med Wochenschr; 1974 Sep; 104(38):1321-6. PubMed ID: 4608626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.